Gene-edited calf may reduce reliance on antimicrobials against cattle disease

The first gene-edited calf with reduced susceptibility to a major viral pathogen, therefore reducing its reliance on antimicrobials, has been unveiled

Cattle worldwide face major health threats from a highly infectious viral disease that decades of vaccinations and other precautions have failed to contain.

Federal, private-sector and Husker scientists are collaborating on a new line of defence, by producing a gene-edited calf resistant to the virus.

If follow-up research confirms its efficacy, the gene-editing approach offers long-term potential to reduce antimicrobial and antibiotic use in the cattle industry.

The bovine viral diarrhoea virus (BVDV) devastates the bovine immune system and can cause severe respiratory and intestinal harm to infected beef and dairy cattle, said veterinary epidemiologist Brian Vander Ley, an associate professor in the University of Nebraska-Lincoln’s School of Veterinary Medicine and Biomedical Sciences.

In utero calves are especially vulnerable to infection. If they survive, they can remain infected for life, repeatedly spreading the virus to other cattle.

Vander Ley, who is also assistant director of UNL’s Great Plains Veterinary Educational Center in Clay Center, said: “They show up as normal cattle but really, they’re shedding a tremendous amount of virus. They’re the ‘Typhoid Marys’ of BVDV spread.”

The cattle industry has vaccinated against the disease since the 1960s, but “the highly mutable nature of BVDV and the emergence of highly virulent strains of BVDV contribute to limited success of present control programmes,” the Academy of Veterinary Consultants has stated.



Bright, healthy calf


Scientists identified the specific genetic structure associated with the disease earlier this century. A collaborative project involving scientists with the USDA’s Agricultural Research Service and Acceligen, a Minnesota-based private company, used gene editing to change the small number of amino acids that lead to BVDV vulnerability, while keeping the rest of the protein, CD46, unchanged.

Aspen Workman, a scientist with ARS’ US Meat Animal Research Center (USMARC) in Clay Center, Nebraska, said: “Our objective was to use gene-editing technology to slightly alter CD46 so it wouldn’t bind the virus yet would retain all its normal bovine functions.”

A gene-edited calf, named Ginger, was born on the 19th July 2021, and was transported to UNL a week later for close monitoring by Vander Ley.

Throughout, Ginger has remained a ‘bright, healthy calf’, normal both physically and behaviourally, which included a week with a BVDV-infected dairy calf that was shedding the virus in great volume.

Ginger is a Gir, a tropically adapted cattle breed used to develop Brahman cattle in North America.

Follow-up research will require experimental replication in other cattle breeds. Ginger also will be monitored through pregnancy, if it occurs.

If the gene-editing approach proves viable, it could potentially reduce the cattle sector’s use of antimicrobials, Vander Ley said.

He stated: “The most successful version of the future that I can see is one where we don’t have to deal with antimicrobial resistance because we just don’t use that many antimicrobials.

“That’s better for everyone.

“That means that we have eliminated the cause of a lot of the antimicrobial use, and we’ve eliminated that expense for livestock producers.”

Michael Heaton, a USMARC researcher for the BVDV project, concurred. This line of research “represents another opportunity to lessen the need for antibiotics in agriculture,” he said.

The research findings is published in PNAS Nexus.

Image: Veterinary epidemiologist Brian Vander Ley of the University of Nebraska-Lincoln’s School of Veterinary Medicine, poses with Ginger, the first gene-edited cow with resistance to bovine viral diarrhoea virus (BVDV). Credit: Craig Chandler/ University Communication/ University of Nebraska-Lincoln.

Research Aether / Technology Uncovered

Leave a reply

Your email address will not be published. Required fields are marked *

Aether: Issue 4 May 2023

Aether: Issue 3 Feb 2023

Aether: Issue 2 Nov 2022

Aether: Issue 1 Aug 2022

Subscribe for free

Latest Testimonial

What a beautiful motto: Discoveries must be read and not just published. When I was contacted by Aether as a new digital service to share scientific and technological insights I had my doubts that this was really going to be according to what I call the “open source & makers’ spirit”: knowledge should be free and it is there to be shared.

Well, Aether is faithful to its motto and shares discoveries freely. It has been a pleasure to collaborate for the interview and subsequent article. It has been greatly self satisfying to see how the interview was professionally and truthfully redacted and then published. Sharing thoughts and sparks for discussions is fundamental to the progress of society. Your journal offers clarity and brevity and I believe it provides the sparks to ignite any reader whether academic or not into action.

Dr Maria-Cristina Ciocci
Co-founder and Manager of non-profit organisation De Creative STEM,GirlsInSTEM